2352
A.T. de Figueiredo et al. / Polyhedron 21 (2002) 2351ꢁ2356
/
2. Experimental
CH2) 7.49 (m, 6H, C6H5), 7.91 (m, 4H, C6H5). FTIR
(KBr): 3122m (n NH), 2956ms (n CH2/CH3), 1594ms
(C6H5), 1563s (C6H5), 1498m, 1470m, 1446m (d CH2),
1380s (n OCN), 1124s (nas 10BO4), 1086vs (nas 11BO4),
993s, 942m (das BO4), 773m (n ONC), 738m (n ONC),
703m (C6H5), 690m (C6H5).
2.1. Instrumental
IR spectra were recorded on a BOMEM FT-IR model
1
BM 100 spectrometer. H NMR spectra were measured
on a BRUKER AC250 instrument with TMS as internal
standard. Elemental analyses (CHN) were determined
2.2.3. Tetra-n-propylammonium
bis(benzohydroximato)borate (3)
with a FISONS EA-1108 equipment. Enrafꢁ
/
Nonius
CAD4 diffractometers were used for the diffraction
measurements. Routine FABꢀ mass spectra have been
recorded on a TSQ spectrometer (Finnigan) with
nitrobenzylalcohol as matrix.
A mixture of 0.031 g H3BO3 (0.50 mmol), 0.058 g Ag2O
(0.25 mmol), 0.137 g benzohydroxamic acid (1.00 mmol),
0.133 g tetra-n-propylammonium bromide (0.50 mmol)
in 25 ml C6H6 was heated to reflux for 8 h as described
above. The solid was filtered off and extracted with 15 ml
CH2Cl2. After vacuum evaporation 0.201 g of 3 (yield
86%) were obtained as colorless crystals (m.p. 136 8C).
Anal. Found: C, 66.41; H, 8.10; N, 8.88. Calc. for
C26H38BN3O4: C, 66.81; H, 8.19; N, 8.99%. NMR
2.2. Preparation of the boron complexes
The hydroximatoborates were prepared as described
previously [14], with slight modifications. Solvents and
commercially available chemicals (H3BO3, benzohy-
droxamic acid, di-n-butylamine, dicyclohexylamine, tet-
ra-n-butylammonium bromide, tetra-n-propylammon-
ium bromide and silver oxide) were used as purchased.
1
(25 8C): H (250 MHz, CDCl3): d 0.84 (t, 12H, CH3),
1.50 (m, 8H, CH2ꢀ
/
CH3), 3.03 (t, 8H, CH2ꢀ
/
N), 7.32 (m,
6H, C6H5), 7.86 (m, 4H, C6H5). FTIR (KBr): 2975ms (n
CH2/CH3), 2945m (n CH2/CH3), 1592ms (C6H5), 1558ms
(C6H5), 1488ms, 1461m, 1447m (d CH2), 1377vs (n
OCN/dCH3), 1114s (nas 10BO4), 1078s (nas 11BO4), 981s,
944m (das BO4), 780m (n ONC), 736m (n ONC), 701ms
(C6H5), 674m. FABꢀ MS; m/z: 281.2, 162.1.
2.2.1. Dicyclohexylammonium
bis(benzohydroximato)borate (1)
A mixture of 0.068 g H3BO3 (1.10 mmol), 0.302 g
benzohydroxamic acid (2.20 mmol) and 0.200 g dicyclo-
hexylamine (1.1 mmol) in 25 ml C6H6 was heated under
reflux for 8 h, using a Dean-Stark trap for azeotropic
elimination of water. After evaporation of the C6H6, the
solid residue was dissolved in 15 ml CH2Cl2, 15 ml n-
2.2.4. Tetra-n-butylammonium
bis(benzohydroximato)borate (4)
Compound 4 has been prepared from 0.062 g H3BO3
(1.00 mmol), 0.274 g benzohydroxamic acid (2.00
mmol), 0.240 g tetra-n-butylammonium bromide (1.00
mmol) and 0.116 g Ag2O (0.50 mmol) as described for 3,
yielding 0.470 g (90%). M.p. 165 8C. Anal. Found: C,
67.64; H, 8.79; N, 8.07. Calc. for C30H46BN3O4: C,
68.83; H, 8.86; N, 8.03%. NMR (25 8C): 1H (250 MHz,
C6H14 was added and the mixture was kept at ꢀ
After 48 h the crystals were filtered off and washed with
n-C6H14 yielding 0.474 g of 1 (yield: 91%). M.p. 226ꢁ
/
15 8C.
/
229 8C. Anal. Found: C, 67.12; H, 6.93; N, 9.12. Calc.
for C26H34BN3O4: C, 67.39; H, 7.40; N, 9.07%. NMR
1
(25 8C): H (250 MHz, CDCl3): d 1.02 (m, 6H, CH2),
CDCl3): d 0.84 (t, 12H, CH3), 1.40 (m, 16H, CH2ꢀ
/
1.47 (m, 4H, CH2), 1.56 (m, 6H, CH2), 1.95 (m, 4H, CH2),
3.10 (m, 2H, CH), 7.26 (m, 6H, C6H5), 7.78 (m, 4H,
C6H5). FTIR (KBr): 3035m (n NH), 2934s (n CH2),
2856s (n CH2), 1597ms (C6H5), 1562ms (C6H5), 1499m,
1447m (d CH2), 1388vs (n OCN), 1125s (nas 10BO4),
1085vs (nas 11BO4), 987s, 942m (das BO4), 792m (n ONC),
742m (n ONC), 691m (C6H5) (IR data: vs, very strong; s,
strong; ms, medium strong; m, medium).
CH3), 3.14 (t, 8H, NꢀCH2), 7.32 (m, 6H, C6H5), 7.86
/
(m, 4H, C6H5). FTIR (KBr): 2966ms (n CH2/CH3),
2929m (n CH2/CH3), 1594m (C6H5), 1558m (C6H5),
1490m, 1382vs (n OCN), 1118s (nas 10BO4), 1083vs (nas
11BO4), 981 s, 944m (das BO4), 770m (n ONC), 737m (n
ONC), 695s (C6H5), 670m (C6H5).
2.3. X-ray crystal structure determinations
2.2.2. Di-n-butylammonium
bis(benzohydroximato)borate (2)
Compound 2 was prepared from 0.080 g H3BO3 (1.30
mmol), 0.357 g benzohydroxamic acid (2.60 mmol) and
0.170 g di-n-butylamine (1.31 mmol) as described above.
Crystals of the chloroform solvate 1×
suitable for structure analysis were obtained from
CHCl3ꢁn-C6H14 solutions (1:1) of the complexes. The
cell constants were calculated from 25 reflexes with a
wide range of 2u. The program HELENA [16] was used
for the data reduction. Both complexes crystallize
monoclinic. The space groups were assigned using the
criterion of choosing the setting which corresponds to
the lowest monoclinic b angle. The structures were
solved by direct methods with SHELXS-97 [17] and
/
CHCl3 and of 3
/
Yield: 0.450 g (84%). M.p. 113ꢁ114 8C. Anal. Found:
/
C, 64.06; H, 6.45; N, 10.28. Calc. for C22H30BN3O4: C,
64.24; H, 7.35; N, 10.22%. NMR (25 8C): 1H (250
MHz, CDCl3): d 0.80 (t, 6H, CH3), 1.3 (m, 4H, CH2ꢀ
/
CH3), 1.79 (m, 4H, CH2ꢀCH2ꢀCH2), 3.10 (t, 4H, Nꢀ
/
/
/